Search

A recent study conducted by the American Cancer Society examined the association between radiotherapy for breast cancer and the risk of developing subtype-specific subsequent primary lung cancer (SPLC) among female breast cancer survivors in the United States. The study found that survivors who received radiotherapy had a higher risk of developing small-cell and squamous cell carcinoma compared to those who did not receive radiotherapy. However, the risk of developing adenocarcinoma did not vary based on radiotherapy receipt. These findings suggest a distinct carcinogenic pathway for radiation-induced lung cancer across histological subtypes and may inform risk-stratified surveillance guidelines for SPLC. [Extracted from the article]

A recent study conducted in Tamil Nadu, India, focused on developing and evaluating biodegradable alginate beads loaded with sorafenib for potential cancer therapy. The research successfully encapsulated sorafenib in the beads, as confirmed by various analytical techniques. The findings suggest that sorafenib-loaded calcium alginate beads could serve as an effective delivery system for cancer treatment, showcasing controlled release properties and specific toxicity against MCF7 breast cancer cells. This research was peer-reviewed and offers valuable insights into innovative approaches for cancer therapy. [Extracted from the article]

A recent study conducted in Cairo, Egypt, focused on the design and synthesis of novel quinazoline-thioacetamide derivatives as anticancer agents, apoptotic inducers, and radio-sensitizers. The research identified compound 9 as a promising anti-tumor agent with potential for further development and modification. Financial support for the study came from the Egyptian Atomic Energy Authority, and the findings were published in the Journal of Molecular Structure. This research provides valuable insights into potential new treatments for cancer therapy and highlights the importance of further investigation into the biological properties of compound 9. [Extracted from the article]

Researchers at the University of Madras in India have synthesized a series of curcumin derivatives to evaluate their potential as anti-breast cancer agents. Through in-silico and in-vitro analysis, these compounds showed promising anti-cancer activity against MCF-7 cell lines, with some compounds exhibiting nontoxic effects on normal cell lines. The study suggests that these compounds could be lead drug materials against breast cancer, offering hope for future treatments. The research was funded by the Department of Science And Technology, Ministry of Science And Technology, India, and the full report can be accessed through Chemical Physics Impact. [Extracted from the article]

Researchers at the First Affiliated Hospital of Anhui University of Chinese Medicine have explored the mechanism of traditional drug treatment for cancer-related ascites using the JiJiaoLiHuang Pill (JJLH). Through network pharmacology analysis and molecular docking, they identified key ingredients and genes involved in the treatment. Their findings suggest that JJLH may inhibit the recurrence of liver cancer malignant ascites by affecting the AQP-3/JAK-STAT-3 pathway. This study provides valuable insights into the potential efficacy of traditional Chinese medicine in managing cancer-related ascites. [Extracted from the article]

A recent study conducted in Tamil Nadu, India, focused on the mathematical modeling of skin cancer induced by ultraviolet radiation. The research aimed to categorize the population into susceptible, infected, recovered, and UV radiation compartments to better understand the dynamics of skin cancer. By utilizing semi-analytical methods such as the differential transform method, the study provided accurate solutions with minimal computational effort, leading to valuable insights into the behavior of the skin cancer model under various conditions. This research enhances our understanding of skin cancer dynamics and offers potential implications for preventive and treatment measures. [Extracted from the article]

A recent study conducted at Taibah University in Saudi Arabia examined the clinicopathological characteristics of surgically treated basal cell carcinomas (BCC) of the face. The study analyzed data from 125 patients admitted to the Department of Oral and Maxillofacial Surgery at the University Medical Center Schleswig-Holstein in Germany. The findings revealed that BCC is the most common nonmelanoma skin cancer, with the nose and temporal region being the most affected areas. The study also highlighted the correlation between certain growth patterns of BCC and recurrence, emphasizing the importance of excision safety margins. When completely excised, the recurrence rate for BCC is relatively low. [Extracted from the article]

A study conducted by the University of Texas MD Anderson Cancer Center examined the experience of African American cancer survivors participating in the Active Living After Cancer (ALAC) program. The ALAC program, administered through the university's Health Disparities Research Department, aims to improve physical activity and physical functioning among African American cancer survivors. The study found that the ALAC program effectively improved physical activity levels, physical functioning, and overall quality of life among participants, regardless of their affiliation with the Project CHURCH partnership. These findings suggest that integrating a curated physical activity program with community-based partnerships can help reduce health disparities and improve survivorship outcomes for African American cancer survivors. [Extracted from the article]

A systematic review conducted by researchers at Hassan II University in Fez, Morocco, examined the prevalence of psychological distress (PD) and coping strategies in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant therapy (NAT). The review included 41 articles and found that the prevalence of depression before NAT ranged from 0% to 46%, while anxiety ranged from 5.5% to 54%. After NAT, the prevalence of depression increased to 40% to 78.5%, while anxiety accounted for 27%. The study also identified determinants of PD, such as perceived social support, living in joint families, COVID-19 infection, delays in diagnosis, and starting neoadjuvant treatment. Coping strategies, such as social support and active coping, were associated with better PD. The researchers concluded that psychological interventions should be implemented to address PD and coping strategies in LABC patients undergoing NAT. [Extracted from the article]

A new report from Taipei, Taiwan discusses a study on cancer treatment. The researchers developed a novel monoclonal antibody called P1801 that targets programmed cell death 1 (PD-1) and programmed death-ligand 1 (PD-L1), which play a role in viral infection and tumor development. The antibody showed unique binding properties and demonstrated significant antitumor activity in mice. The researchers plan to conduct a Phase 1 clinical study to test its combination use with another drug for cancer treatment. [Extracted from the article]

Researchers at the PG & Research Department of Chemistry in Tamil Nadu, India, have developed and evaluated chitosan/lysine nanoparticles as a delivery system for capecitabine in cancer treatment. The nanoparticles were synthesized and characterized, showing successful drug loading and ideal particle sizes for tumor penetration. The formulation achieved a high drug entrapment efficiency and sustained drug release. The nanoparticles also exhibited antioxidant potential and efficacy against certain microbes. Molecular docking analysis suggested potential anti-inflammatory properties. This research highlights the potential of chitosan-lysine nanoparticles as effective carriers for capecitabine in cancer treatment and their potential in anti-inflammatory applications. [Extracted from the article]

A recent study conducted by researchers at the University of Madras in Tamil Nadu, India, has yielded new findings on anticancer agents. The researchers synthesized a new curcumin derivative and examined its structure, molecular interactions, and anticancer activity. The compound showed high toxicity against HEK293 cell lines and demonstrated efficacy as an anticancer agent in MCF-7 cell lines. Molecular docking simulations indicated that the compound could be a potential drug candidate. Further biological and pharmaceutical investigations are needed to confirm its suitability as a drug. [Extracted from the article]

A report from researchers at Bharathidasan University discusses the findings of a study on anticancer agents. The researchers focused on a specific molecule, (S)-3-Benzyl-5-(phenylselanyl)-6-(p-tolyl)-3,4-dihydropyran-2-one (3B6PL), and used computational calculations and analytical techniques to characterize its molecular structure. The study also explored the molecule's electrical properties, non-linear optical characteristics, and intermolecular interactions. In addition, in-silico analysis and molecular docking were conducted to assess the molecule's potential as an anticancer agent. The researchers concluded that further analysis is needed to determine its cytotoxicity and potential for enhancement. [Extracted from the article]

A recent study conducted by researchers at the Autonomous University of Coahuila has shed light on liver cancer, specifically hepatocellular carcinoma. The study focused on a rare phenomenon known as cannonball metastases, which are multiple solid lesions found in the lungs. The researchers presented a case report of a 59-year-old man who exhibited these lesions along with a heterogeneous lesion in the liver. The findings highlight the importance of timely diagnosis and suspicion of hepatocellular carcinoma in patients with this radiographic pattern. The study concludes that cannonball metastases in hepatocellular carcinoma are rare and indicate a poor prognosis. [Extracted from the article]

A recent study published in the Journal of Surgical Protocols and Research Methodologies explores the therapeutic potential of dendritic cell vaccines in treating glioblastoma, a primary malignant brain tumor. The study aims to gather evidence-based information on the effectiveness of dendritic cell vaccines in triggering an anticancer immune system reaction. The researchers plan to conduct a systematic review and meta-analysis using four primary central databases as sources of information. The study findings will be published in journals and presented at conferences for broader dissemination. Despite multimodal treatment, glioblastoma remains challenging to treat, with a median survival of just 15 months. [Extracted from the article]

A recent study conducted at the King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia, explores the genetic risk factors and clinical outcomes in childhood eye cancers. The researchers emphasize the importance of understanding these genetic factors for early detection, risk assessment, and the development of targeted therapies. The study also discusses the implications of these genetic discoveries in treating pediatric ocular cancer, highlighting the significance of genetic research in guiding early interventions and improving outcomes for children with ocular cancers. This research provides valuable insights into the various types of ocular tumors and advancements in managing these conditions. [Extracted from the article]

A recent study conducted in Mozambique found that there is a lack of knowledge about cervical cancer among women with the disease. The study, which took place in the city of Xai-Xai, surveyed 60 women diagnosed with cervical cancer. The results showed that many of the women had misconceptions about the causes and prevention of cervical cancer. The researchers concluded that there are significant gaps in awareness of cervical cancer among high-risk groups. [Extracted from the article]

Keywords: Adenocarcinoma; Antibodies; Biochemicals; Biochemistry; Biological Products; Blood Proteins; Cancer; Chemicals; Drugs and Therapies; Health and Medicine; Hormones; Immunization; Immunoglobulins; Immunology; Oncology; Proteins; Public Health; Radiotherapy; Vaccination; Vaccine Candidates; Vaccines EN Adenocarcinoma Antibodies Biochemicals Biochemistry Biological Products Blood Proteins Cancer Chemicals Drugs and Therapies Health and Medicine Hormones Immunization Immunoglobulins Immunology Oncology Proteins Public Health Radiotherapy Vaccination Vaccine Candidates Vaccines 1376 1376 1 10/30/23 20231103 NES 231103 2023 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on adenocarcinoma. Every patient included in the study had a diagnosis of locally advanced prostate adenocarcinoma at stages 3 and 4 and received immunization with the vaccine candidate. [Extracted from the article]

Aniline Compounds, Antibiotics, Biotechnology, Cancer, Carcinomas, Drugs and Therapies, Health and Medicine, Heart, Heart Research, Liver Cancer, Myocardium, Oncology, Organic Chemicals, Pharmaceuticals, Sulfanilamides, Sulfapyridine, Sulfapyridine Therapy, Sulfones, Sulfur Compounds Keywords: Aniline Compounds; Antibiotics; Biotechnology; Cancer; Carcinomas; Drugs and Therapies; Health and Medicine; Heart; Heart Research; Liver Cancer; Myocardium; Oncology; Organic Chemicals; Pharmaceuticals; Sulfanilamides; Sulfapyridine; Sulfapyridine Therapy; Sulfones; Sulfur Compounds EN Aniline Compounds Antibiotics Biotechnology Cancer Carcinomas Drugs and Therapies Health and Medicine Heart Heart Research Liver Cancer Myocardium Oncology Organic Chemicals Pharmaceuticals Sulfanilamides Sulfapyridine Sulfapyridine Therapy Sulfones Sulfur Compounds 30 30 1 09/11/23 20230914 NES 230914 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Fresh data on liver cancer are presented in a new report. [Extracted from the article]

Keywords: Bioengineering; Biotechnology; Cancer; Drugs and Therapies; Engineering; H. Lee Moffitt Cancer Center & Research Institute; Health and Medicine; Heparin Therapy; Oncology; Pharmaceuticals EN Bioengineering Biotechnology Cancer Drugs and Therapies Engineering H. Lee Moffitt Cancer Center & Research Institute Health and Medicine Heparin Therapy Oncology Pharmaceuticals 416 416 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- TAMPA, Fla. - Moffitt Cancer Center has launched the Department of Bioengineering. The new academic research department will be housed within the Division of Basic Science and led by W. Gregory Sawyer, Ph.D. Bioengineering integrates the disciplines of engineering and cancer biology. [Extracted from the article]

Keywords: Cancer; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Health and Medicine; Oncology EN Cancer Drug Delivery Drug Delivery Systems Drugs and Therapies Health and Medicine Oncology 1103 1103 1 05/15/23 20230519 NES 230519 2023 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on cancer have been presented. Keywords for this news article include: Portuguese Oncology Institute, Cancer, Oncology, Drugs and Therapies, Health and Medicine, Drug Delivery Systems. Cancer, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Health and Medicine, Oncology. [Extracted from the article]

Keywords: Cancer; Genetics; Health and Medicine; Human Papillomavirus; Oncology; Oropharyngeal Cancer EN Cancer Genetics Health and Medicine Human Papillomavirus Oncology Oropharyngeal Cancer 778 778 1 05/08/23 20230509 NES 230509 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on oropharyngeal cancer have been published. Cancer, Genetics, Health and Medicine, Human Papillomavirus, Oncology, Oropharyngeal Cancer. [Extracted from the article]

For more information on this research see: Pyrazole-sulfonamide scaffold featuring dual-tail strategy as apoptosis inducers in colon cancer. Keywords: Amides; Apoptosis; Cancer; Cellular Physiology; Colon Cancer; Health and Medicine; Oncology; Sulfonamides; Sulfones; Sulfur Compounds EN Amides Apoptosis Cancer Cellular Physiology Colon Cancer Health and Medicine Oncology Sulfonamides Sulfones Sulfur Compounds 885 885 1 04/24/23 20230425 NES 230425 2023 APR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New study results on colon cancer have been published. [Extracted from the article]

Keywords: Bilthoven; Netherlands; Europe; Cancer; Health and Medicine; Oncology EN Bilthoven Netherlands Europe Cancer Health and Medicine Oncology 366 366 1 04/17/23 20230418 NES 230418 2023 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Cancer have been presented. Netherlands, Europe, Cancer, Health and Medicine, Oncology, Bilthoven. [Extracted from the article]

Tamil Nadu, India, Asia, Bone Research, Cancer, Cell Line, Drugs and Therapies, Health and Medicine, Oncology Keywords: Tamil Nadu; India; Asia; Bone Research; Cancer; Cell Line; Drugs and Therapies; Health and Medicine; Oncology EN Tamil Nadu India Asia Bone Research Cancer Cell Line Drugs and Therapies Health and Medicine Oncology 176 176 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Cancer have been published. [Extracted from the article]

Keywords: Bladder Cancer; Cancer; Carcinomas; Epidemiology; Health and Medicine; Oncology; Ring Cell Cancer; Ring Cell Carcinoma; Signet-Ring Cell Carcinoma EN Bladder Cancer Cancer Carcinomas Epidemiology Health and Medicine Oncology Ring Cell Cancer Ring Cell Carcinoma Signet-Ring Cell Carcinoma 2023 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Investigators discuss new findings in ring cell cancer. Keywords for this news article include: Department of Urology, Oncology, Epidemiology, Bladder Cancer, Ring Cell Cancer, Health and Medicine, Signet-Ring Cell Carcinoma. Cancer, Carcinomas, Epidemiology, Health and Medicine, Oncology, Ring Cell Cancer, Ring Cell Carcinoma, Signet-Ring Cell Carcinoma, Bladder Cancer. [Extracted from the article]

Ascites, Cancer, Clinical Research, Clinical Trials and Studies, Colon Cancer, Colorectal Research, Gastroenterology, Health and Medicine, Oncology Keywords: Ascites; Cancer; Clinical Research; Clinical Trials and Studies; Colon Cancer; Colorectal Research; Gastroenterology; Health and Medicine; Oncology EN Ascites Cancer Clinical Research Clinical Trials and Studies Colon Cancer Colorectal Research Gastroenterology Health and Medicine Oncology 2023 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Fresh data on colon cancer are presented in a new report. [Extracted from the article]

Keywords: Business; Cancer; Health and Medicine; Oncology; Prostate Cancer; Prostatic Neoplasms EN Business Cancer Health and Medicine Oncology Prostate Cancer Prostatic Neoplasms 2023 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on prostate cancer have been presented. Keywords for this news article include: R&D Department, Business, Oncology, Prostate Cancer, Health and Medicine, Prostatic Neoplasms. [Extracted from the article]